Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Elżbieta Senkus, S. Kyriakides, Frédérique Penault‐Llorca, et al.
Annals of Oncology (2013) Vol. 24, pp. vi7-vi23
Open Access | Times Cited: 453

Showing 1-25 of 453 citing articles:

Breast cancer
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2258
The Obesity Paradox in Cancer: a Review
Hannah Lennon, Matthew Sperrin, Ellena Badrick, et al.
Current Oncology Reports (2016) Vol. 18, Iss. 9
Open Access | Times Cited: 500
The expanding role of primary care in cancer control
Greg Rubin, Annette J. Berendsen, S. M. Crawford, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 12, pp. 1231-1272
Open Access | Times Cited: 480
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Sara A. Hurvitz, Miguel Martín, W. Fraser Symmans, et al.
The Lancet Oncology (2017) Vol. 19, Iss. 1, pp. 115-126
Open Access | Times Cited: 430
Genomic alterations in lung adenocarcinoma
Siddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan
The Lancet Oncology (2015) Vol. 16, Iss. 7, pp. e342-e351
Closed Access | Times Cited: 363
Follow-up strategies for women treated for early breast cancer
Ivan Moschetti, Michela Cinquini, Matteo Lambertini, et al.
Cochrane library (2016) Vol. 2016, Iss. 5
Open Access | Times Cited: 331
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies
Mohamed Ismail Nounou, Fatema ElAmrawy, Nada A. Ahmed, et al.
Breast Cancer Basic and Clinical Research (2015) Vol. 9s2, pp. BCBCR.S29420-BCBCR.S29420
Open Access | Times Cited: 319
Biology and Management of Patients With Triple-Negative Breast Cancer
Priyanka Sharma
The Oncologist (2016) Vol. 21, Iss. 9, pp. 1050-1062
Open Access | Times Cited: 255
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
Fausto Petrelli, Giuseppe Viale, Mary Cabiddu, et al.
Breast Cancer Research and Treatment (2015) Vol. 153, Iss. 3, pp. 477-491
Closed Access | Times Cited: 246
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
Michael J. Duffy, Patricia M. McGowan, Nadia Harbeck, et al.
Breast Cancer Research (2014) Vol. 16, Iss. 4
Open Access | Times Cited: 242
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
Milena Sant, María Dolores Chirlaque López, Roberto Agresti, et al.
European Journal of Cancer (2015) Vol. 51, Iss. 15, pp. 2191-2205
Open Access | Times Cited: 232
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative
Athan Baillet, Laure Gossec, Loreto Carmona, et al.
Annals of the Rheumatic Diseases (2016) Vol. 75, Iss. 6, pp. 965-973
Closed Access | Times Cited: 217
Trastuzumab in the Treatment of Breast Cancer
Sofia Maximiano, Paulo Magalhães, Mara Pereira Guerreiro, et al.
BioDrugs (2016) Vol. 30, Iss. 2, pp. 75-86
Closed Access | Times Cited: 197
Quality indicators in breast cancer care: An update from the EUSOMA working group
Laura Biganzoli, Lorenza Marotti, Christopher D. Hart, et al.
European Journal of Cancer (2017) Vol. 86, pp. 59-81
Closed Access | Times Cited: 188
The relevance of EMT in breast cancer metastasis: Correlation or causality?
Ruben Bill, Gerhard Christofori
FEBS Letters (2015) Vol. 589, Iss. 14, pp. 1577-1587
Open Access | Times Cited: 186
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
Xavier Pivot, Joseph Gligorov, Volkmar Müller, et al.
Annals of Oncology (2014) Vol. 25, Iss. 10, pp. 1979-1987
Open Access | Times Cited: 149
Management of locally advanced breast cancer—perspectives and future directions
Konstantinos Tryfonidis, Elżbieta Senkus, Maria João Cardoso, et al.
Nature Reviews Clinical Oncology (2015) Vol. 12, Iss. 3, pp. 147-162
Closed Access | Times Cited: 144
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial
Nadia Harbeck, Chiun‐Sheng Huang, Sara A. Hurvitz, et al.
The Lancet Oncology (2016) Vol. 17, Iss. 3, pp. 357-366
Closed Access | Times Cited: 141
POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases
Amit Goyal, David Dodwell
Clinical Oncology (2015) Vol. 27, Iss. 12, pp. 692-695
Closed Access | Times Cited: 139
Breast cancer biomarker (HER2-ECD) detection using a molecularly imprinted electrochemical sensor
João G. Pacheco, Patrícia Rebelo, María Freitas, et al.
Sensors and Actuators B Chemical (2018) Vol. 273, pp. 1008-1014
Open Access | Times Cited: 129
Improving Analgesic Efficacy and Safety of Thoracic Paravertebral Block for Breast Surgery: A Mixed-Effects Meta-Analysis
Abdullah Sulieman Terkawi
Pain Physician (2015) Vol. 5;18, Iss. 5;9, pp. E757-E780
Open Access | Times Cited: 121
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 23, pp. 5820-5829
Open Access | Times Cited: 113
The role of the GP in follow-up cancer care: a systematic literature review
Judith Meiklejohn, Alexander Mimery, Jennifer Martin, et al.
Journal of Cancer Survivorship (2016) Vol. 10, Iss. 6, pp. 990-1011
Closed Access | Times Cited: 109
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population
Mustapha Abubakar, Hyuna Sung, Devi BCR, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 100
Biomarkers in Breast Cancer
Michael J. Duffy, Siún Walsh, Enda McDermott, et al.
Advances in clinical chemistry (2015), pp. 1-23
Closed Access | Times Cited: 99
Page 1 - Next Page

Scroll to top